| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.011 | 1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.0037 | 1 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |